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Background: The purpose of this study was to investigate the effects and mechanisms of dihydrotestosterone
(DHT)-induced expression of sterol regulatory element binding protein-1 (SREBP-1), and the synthesis and secretion
of lipids, in HaCaT cells. HaCaT cells were treated with DHT and either the phosphoinositide 3-kinase inhibitor
LY294002 or the extracellular-signal-regulated kinase (ERK) inhibitor PD98059. Real time-PCR, Western blot, Oil Red
staining and flow cytometry were employed to examine the mRNA and protein expressions of SREBP-1, the gene
transcription of lipid synthesis, and lipid secretion in HaCaT cells.
Findings: We found that DHT upregulated mRNA and protein expressions of SREBP-1. DHT also significantly
upregulated the transcription of lipid synthesis-related genes and increased lipid secretion, which can be inhibited
by the addition of LY294002.
Conclusions: Collectively, these results indicate that DHT induces SREBP-1 expression and lipogenesis in HaCaT
cells via activation of the phosphoinositide 3-kinase/Akt Pathway.
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Excessive secretion of sebum on skin is an important
factor in various skin diseases, including acne and sebor-
rheic dermatitis [1,2]. Besides sebaceous glands, kerati-
nocytes are another important source of lipid on skin
surface (2). Although the epidermis is certainly affected
by steroid hormones, little is known about the effects of
androgens on human keratinocytes. Previous studies
demonstrated that in sebaceous glands androgens regu-
lates the synthesis of sebum lipids through the sterol
regulatory element-binding protein (SREBP) pathway [3].
Nevertheless, results of investigations on androgens re-
ceptor expression in keratinocytes are controversial: some
groups have demonstrated that the androgens receptor is
expressed in the epidermis [4], while others reported its
absence [5]. Although nothing in the literature so far sug-
gests that testosterone or its analog dihydrotestosterone* Correspondence: daniluo2005@yahoo.com.cn
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reproduction in any medium, provided the or(DHT) effect the growth of keratinocytes, we found that
these hormones were associated with SREBP-1 expression
in cells of the immortalized keratinocyte cell line HaCaT,
which are quite similar to primary normal keratinocytes
in steroid-metabolizing activity and responsiveness to
steroid hormones [6].
The SREBP transcription factors bind sterol response
elements, and three members of the SREBP family have
been identified: SREBP-1a, SREBP-1c, and SREBP-2 [7].
In spite of the partial functional overlap between
SREBP-1 and SREBP-2, SREBP-1 typically regulates
genes in the fatty acid biosynthesis pathway, whereas
SREBP-2 modulates the transcription of genes asso-
ciated with cholesterol biosynthesis [8]. DHT has been
reported to regulates SREBP-1 expression in various
cell lines and organs [3,9,10]. Besides that, SREBP-1
was also found to be expressed in keratinocytes and
played an important role in its lipid synthesis [11].
However, little is known of how DHT impacts the
function of SREBP-1 in keratinocyte HaCaT cells. The
aim of this study was to dissect the molecular signalingtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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mRNA and protein levels of SREBP-1 in HaCaT cells.
Materials and methods
Materials
Dihydrotestosterone (DHT) powder was bought from
Sigma Co. Ltd. DHT was diluted with DMSO just before
use, and prepared in serum-free medium at required
concentrations, subpackaged by Filtration sterilization.
Anti SREBP-1 (polyclonal) was bought from Beijing
Bo’ao Bio-tech Co. Ltd.; Rabbit anti phospho-Akt
(Ser473) and anti-total Akt was bought from Cell Signal-
ing; Mouse anti phospho-p44/42 MAPK, anti total p44/
42 MAPK, Mouse anti phospho-JNK/SAPK, Rabbit anti
phospho-P38 MAPK, Mouse/Rabbit anti Actin, PI3K in-
hibitor LY294002, MEK inhibitor PD98059, BCA Protein
Assay Kit were all bought from Beyotime Institute of
Biotechnology; Trizol was bought from Invitrogen; Real-
time PCR Assay Kits were bought from Nanjing KGI
Bioteknologi Development Co, Ltd.; Nile red powder
was bought from Shanghai XinRan Bio-tech Co, Ltd,
diluted with methanol and stored at a concentration of
10μg/mL at 4°C, away from light.
Method
Cell culture
Keratinocyte line HaCaT cells were cultured in a cell in-
cubator at 37°C, 5% CO2, in DMEM medium containing
10% fetal bovine serum and 1% penicillin and strepto-
mycin. After cells became polygon arranging as a single
layer, they were vaccinated at the density of 1*10 9/L
with 0.25% trypsin solution. The cultured cells were used
for experiment when they adhered to the culture plat
and the confluence reached 70%~80%.
Experiment grouping and treatment of cells
To examine the effect of DHT on the expression of
SREBP-1 and the activation of the phosphoinositide
3-kinase (PI3k)/Akt and mitogen-activated protein kin-
ase (MAPK) pathways in HaCaT cells, the cells were
first randomly divided into 4 groups based on DHT
treatment concentrations: 0 (control), 10, 100, and 1000
nM. DHT at a concentration of 100 nmol/L was taken
as the stimulus quantity, and random groups were cre-
ated: a control group; α a DHT group at a concentra-
tion of 100nmol/L; βPD98059 group, pretreated with
PD98059 at 50μM for 40 min; χ LY294002 group, pre-
treated with LY294002 at 50μM for 40min; δPD98059
+DHT group, pretreated with PD98059 at 50μM for 40
min, then with DHT added at concentration of 100
nmol/L; ε LY294002+DHT group, pre-treated with
LY294002 at 50μM for 40min, then with DHT added at
concentration of 100nmol/L. Every group was cultured
for 24 hours before further tests.Real-time PCR detection of the expression of SREBP-1 mRNA
and the expression of lipogenic enzyme (FAS, ACS, SCD,
HMGCR) mRNA in HaCaT cells
Cells were grouped according to experimental grouping
requirements. Trizol was added to break down the cells,
followed by extraction of total RNA, measurement of
concentration and then measurement of purity. After
ensuring that the quality met the requirements of the
experiment, cDNA was obtained by reverse transcrip-
tion. It was diluted 10 times and amplified according to
a 20μL reaction system. Primers were synthesized by
Nanjing Kaiji Bio-tech Co, Ltd (Additional file 1 Table S1).
Amplification conditions: pre-degeneration at 95°C for
5 min, entering reaction circles, degeneration at 95°C for
15 min, annealing for 30s at 60°C, extending for 30s at
72°C, keeping at 72°C for 10 min after 40 circles.
Western blotting tests for the protein expression of SREBP-1,
p-AKT, p-P38 and p-JNK
The cells were treated according to experiment grouping
methods, the culture solution was discarded, the cells
were washed 3 times with PBS solution pre-cooled to 4°C,
300ul cell degradation solution containing protease inhibi-
tor was added, the mixture was placed on ice for 15min,
cells were detached and centrifugal separation was con-
ducted at 4°C at 12000rpm. The upper layer solution was
taken for protein testing by the BCA method. A 30μg
sample of protein was taken from each group for SDS-
PAGE electrophoresis testing, and protein was transferred
onto PVDF films, covered with a 5% BSA blocking buffer
at 37°C for 1 hour. The primary antibody was added
according to the experiment requirements (Rabbit anti-
body SREBP-1, dilutedat 1:500, Rabbit antibody phospho-
AKT, diluted at 1:1000, Rabbit antibody total-AKT, diluted
at 1:1000; mouse antibody phospho-ERK, diluted at
1:1000, mouse antibody total-ERK, diluted at 1:1000;
Rabbit antibody phospho-P38, diluted at 1:1000; mouse
antibody phospho-JNK, diluted at 1:1000; Actin antibody
diluted at 1:1000), kept in incubation at 4°C throughout
the night, washed before being incubated with the second-
ary antibody, which was diluted at 1:1000 and marked by
horseradish peroxidase, at 37°C for 40 min. ECL detection
reagent was added for 5min, and finally squash, develop-
ment and fixation were conducted.
Observing the DHT-induced lipid droplet changes in HaCaT
cells by the Oil Red staining method
HaCaT cells were inoculated at exponential phase in
12-well plates, 3×104 for each well, and cultured for
24 hours. HaCaT cells were treated according to experi-
ment grouping methods, and after the culture medium
solution was carefully discarded were washed with PBS
solution 3 times, then fixed with 4% paraformaldehyde
for 10min. The cells were colored with Oil Red staining
Zhou et al. Lipids in Health and Disease 2012, 11:156 Page 3 of 6
http://www.lipidworld.com/content/11/1/156solution for 20min,washed with 60% isopropanol solu-
tion for 30s, washed with distilled water for 30s until
the background was clear, and then the culture plates
were placed upside down under a microscope and
photographed with Leica Qwin Plus (plain light).Detecting the synthesis of lipid in HaCaT cells by flow
cytometer
HaCaT cells at exponential phase of growth were inocu-
lated in 6-well plates, 3×104 for each well, and cultured for























































Figure 1 The effects of the PI3K inhibitor (LY294002) and ERK inhibito
cells. (A) LY294002 and PD98059 distinctly inhibited the DHT-induced prot
inhibited the DHT-induced expression of SREBP-1 mRNA, while PD98059 ha
SREBP-1. (C) LY294002 inhibited the DHT-induced protein expression of SRE
expression of protein SREBP-1. Data are means±SD of three independent e
DHT group.experiment grouping methods, and 0.25% trypsin solution
containing 0.02%EDTA was added. The degradation
process was ended with10% fetal calf serum medium. The
cells were washed 2 times with PBS, single cell suspension
was prepared (in PBS), 100ng/mL nile red fluorescent dye
was added, samples were incubated at room temperature
for 15min, filtered with 300 mesh nylon membrane, and
then flow cytometry was used to test 10000 cells of each
sample . The average fluorescence intensity of every cell
was calculated, with excitation wavelength at 485nm and








r (PD98059) on DHT-induced expression of SREBP-1 in HaCaT
ein expressions of p-Akt and p-ERK, respectively. (B) LY294002
s no significant effect on the DHT-induced mRNA expression of
BP-1, while PD98059 has no significant effect on the DHT-induced
xperiments. * P < 0.01 vs. untreated control group; # P < 0.05 vs.
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SPSS13.0 software was used for data analysis, and the
form of average±standard deviation xþsð Þ was used to
indicate measurement data. ANOVA was used for inter-
group comparison, P<0.05 was considered statistically
significant.
Results and discussion
DHT treatment increased SREBP-1a and SREBP-1c
mRNA levels and SREBP-1 protein expression in HaCaT
cells in a dose-dependent manner (Additional file 2 Figure
S1a-b). p-AKT in the PI3k/Akt pathway and p-ERK path-
way were also significantly upregulated by DHT in a
dose-dependent manner. However, DHT has no effect
on the p-P38 and p-JNK expression in the MAPK

















































Figure 2 The effect of LY294002 on DHT-induced expression of lipid
(A) The effect of LY294002 on the synthesis of lipids, as shown using Oil Re
tested using flow cytometry. (C) The effect of LY294002 on DHT-induced e
Data are means±SD of three independent experiments. * P < 0.01 vs. untreinhibitor LY294002 and the ERK inhibitor PD98059
could reverse the activation of p-Akt and p-ERK
(Figure 1-A), respectively, and their effects on DHT-
induced SREBP-1c expression were different: LY294002
inhibited the DHT-induced activation of SREBP-1, but
PD98059 had little effect (Figure 1, B, C). Compared with
the control group, DHT stimulated HaCaT cells to
synthesize more lipid droplets. After pretreatment with
LY294002, the droplets were significantly abolished
(Figure 2a), which was consistent with the results from
flow cytometry analysis of Nile Red fluorescent dye in-
tensity (Figure 2b). FAS, ACS, SCD, and HMGCR are all
important enzymes with a role in lipid synthesis, whose
gene transcription is regulated by SREBP-1 [12]. When
DHT was introduced, the mRNA levels of FAS, ACS,








synthetase-related genes and lipid synthesis in HaCaT cells.
d staining. (B) The effect of LY294002 on the synthesis of lipids, as
xpression of lipid synthetase related genes, as tested by real-time PCR.
ated control group; # P < 0.05 vs. DHT group.
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effects (Figure 2c).
Abundant secretion of lipid in epidermis and sebaceous
glands caused by androgen contributes in a major way to
the occurrence of diseases like acne and seborrheic
dermatitis. The process of lipid synthesis involves the acti-
vation of lipid synthesis related enzyme genes in combin-
ation with regulatory factors. SREBPs were discovered to
be the major nuclear transcription factors contributing to
the regulation of lipid synthesis and secretion, being able
to activate the transcription process of such enzyme genes
as FAS, ACS, SCD, HMGCR, and in this way stimulating
lipid synthesis and secretion [11,13-15]. In recent years,
much attention has been focused on intracellular signal
transduction mediating the activation of the SREBP path-
way, which plays a role in lipogenesis. The PI3K/Akt sig-
naling and MAPK pathways both play important roles in
mediating the activation of the SREBP pathway [16]. With
differences in tissue and cell types and different stimula-
tion factors there are differences in the signaling pathways
which activate the SREBP pathway. Yang YA et al. [17]
found that P13k/Akt and ERK/MAPK signaling pathways
may play a role in regulation of the expression of SREBP-1
and the transcription of FAS in breast cancer. KGF can in-
duce the expression of SREBP-1 in H292 lung cancer cells
through two pathways (JNK and PI3K/Akt), so enhancing
the expression of SCD-1 and FAS [18]. Smith TM et al.
[12] studied the effects of PI3k/Akt and MAPK pathways
on the IGF-1-induced expression of SREBP-1 in sebocytes
and found that PI3k/Akt played an important role in this
process. Our results shows that whether the PI3k/Akt
pathway is activated or not has a close bearing on the
expression of SREBP-1 induced by DHT, which may be
important and specific in DHT treated keratinocyte
HaCaT cells.
Recent reports indicate that activation of Akt is involved
in the transport of the SREBP cleavage-activating protein
(SCAP)/SREBP complex from the endoplasmic reticulum
to the Golgi [19]. This is a major regulatory step in SREBP
activity. Our data indicate that DHT increases the amount
of cleaved (mature) SREBP protein and that this increase
is inhibited in the presence of LY294002 (Figure 1b,c).
This suggests that, in addition to possible transcriptional
and translational control, Akt activation may also affect
SREBP processing in HaCaT cells. Akt activation has been
shown to increase the expression of lipogenic genes [16].
The conclusion is further supported by our observation
that inhibition of Akt activation by LY294002 blocks the
increase in mRNA expression of lipogenic genes and lipo-
genesis induced by SREBP-1 (Figure 2c).
Conclusions
In conclusion, our investigations suggest that DHTcan ac-
tivate SREBP-1 and lipogenesis in HaCaT cells and thatthe PI3k/Akt signaling pathway has important regulatory
effects on lipid synthesis and secretion induced by DHT.
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